youtube_live
Q1 2027 earnings • released • EPS beat +85.71% • Revenue miss -3.62%
See resultschevron_right
TLRY:NASDAQ
Tilray Brands Inc
$3.59
arrow_downward
-3.36%(-0.12) 1D
$3.62
arrow_upward
+0.84% (+0.030)bedtimeAfter hours
Closed: Oct 8, 4:00:00 PM GMT-4 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TLRY...
Open
$3.49
High
$3.67
Low
$3.38
Mkt. cap
530.54M
Avg. vol.
3.76M
Volume
9.30M
52-wk high
$23.20
52-wk low
$3.38
EPS
-$1.09
Beta
1.91
Shares outstanding
147.78M
No. of employees
4K
Open
$3.49
High
$3.67
Low
$3.38
Mkt. cap
530.54M
Avg. vol.
3.76M
Volume
9.30M
52-wk high
$23.20
52-wk low
$3.38
EPS
-$1.09
Beta
1.91
Shares outstanding
147.78M
No. of employees
4K
News stories
From web sources and news partners
MarketBeat
·
41 minutes ago
Tilray Brands (NASDAQ:TLRY) Stock Falls 3.2% - Should You Sell?
News Corp
·
1 hour ago
Tilray Brands Inc. stock falls Thursday, underperforms market
MarketWatch
·
1 hour ago
Tilray Brands Inc. stock falls Thursday, underperforms market
TradingView
·
1 hour ago
Tilray Brands, Inc. Q1 2027: Revenue $257.1M, EPS $(0.32) — 10-Q Summary
Profile
Tilray Brands, Inc. is an American pharmaceutical, cannabis-lifestyle and consumer packaged goods company, incorporated in the United States, headquartered in New York City. Tilray also has operations in Canada, Australia, New Zealand, Latin America, with growing facilities in Germany, Portugal and the United Kingdom.
In December 2020, the company announced a merger with Aphria, and now operates under the Tilray name and its ticker symbol on NASDAQ and the Toronto Stock Exchange.
Tilray also owns several breweries and was ranked by the Brewers Association as the 4th largest craft beer company in the US in 2025. Wikipedia
About Tilray Brands Inc
CEOIrwin D.Simon
Employees3.6K
Founded2013
HeadquartersNew York, New York, Canada
SectorPharmaceutical industry
Website-
Analyst ratings
Based on 5 analysts giving stock ratings to TLRY in the past 3 months
Buy
Buy
2
Hold
3
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for TLRY in the last 3 months.
Highest
Current $3.59
$10.00 (+178.55%)
Average
$5.46 (+52.09%)
Lowest
$2.81 (-21.84%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Derek Lessard TD Cowen | Buy | Reiterated | $4.50 | +25.3% | 10/05/2026 |
Bill Kirk Roth MKM | Buy | Maintained | $10.00 | +178.6% | 10/06/2026 |
Unknown Analyst Roth MKM | Buy | Maintained | $10.00 | +178.6% | 10/06/2026 |
Aaron Grey Alliance Global Partners | Hold | Maintained | $4.00 | +11.4% | 10/05/2026 |
Neal Gilmer Haywood | Hold | Maintained | CA$4.00 | +11.4% | 10/02/2026 |
Frederico Gomes ATB Cormark Capital Markets | Hold | Maintained | $6.00 | +67.1% | 09/21/2026 |
Robert Moskow TD Cowen | Buy | Reiterated | $5.00 | +39.3% | 07/31/2026 |
Unknown Analyst Bernstein | Hold | Maintained | $6.50 | +81.1% | 06/25/2026 |
Nadine Sarwat Bernstein | Hold | Reiterated | - | - | 05/12/2026 |
Kenric Tyghe Canaccord Genuity | Hold | Maintained | CA$9.50 | +164.6% | 04/02/2026 |
Last report
Just released
Today, 8:30 AM
Fiscal period
Q1 2027
EPS / Est. (USD)
-$0.02 / -$0.14
+85.71%beat
arrow_upward
Revenue / Est. (USD)
257.15M / 266.80M
-3.62%miss
arrow_downward
Fiscal Q1 2027 earnings call
youtube_liveWaiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Aug 2025 | Nov 2025 | Feb 2026 | May 2026 |
|---|---|---|---|---|
Revenue | 209.50M | 217.51M | 206.73M | 281.71M |
Cost of goods sold | 152.03M | 160.01M | 151.78M | 189.04M |
Cost of revenue | 152.03M | 160.01M | 151.78M | 189.04M |
Research and development expenses | 41.00K | 78.00K | 62.00K | 180.00K |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 64.13M | 72.94M | 69.54M | 88.64M |
Operating expense | 68.10M | 77.37M | 74.70M | 95.01M |
Total operating expenses | 220.13M | 237.38M | 226.48M | 284.06M |
Operating income | -10.63M | -19.88M | -19.75M | -2.34M |
Other non operating income | -3.14M | -1.64M | -234.00K | 3.62M |
EBT including unusual items | -772.00K | -39.96M | -23.26M | -24.07M |
EBT excluding unusual items | -13.54M | -37.22M | -12.48M | -7.82M |
Income tax expense | -2.28M | 3.55M | 1.97M | 13.86M |
Effective tax rate | 295.98% | -8.87% | -8.49% | -57.60% |
Other operating expenses | - | - | - | - |
Net income | -322.00K | -44.93M | -26.57M | -49.57M |
Net profit margin | -0.15% | -20.66% | -12.85% | -17.60% |
Earnings per share | - | -0.02 | 0.02 | 0.05 |
Interest and investment income | - | - | - | 6.25M |
Interest expense | -6.70M | -5.37M | -4.96M | -12.88M |
Net interest expenses | -6.70M | -5.37M | -4.96M | -6.63M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | 4.93M | -3.92M | -3.01M | 17.00M |
Gain or loss from assets sale | - | - | - | -509.00K |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1